Discovering the true signals of disease to power life-changing medicines51-200 Employees
Sequence Bio Funding
$3M
11 round
Y Combinator
Sequence Bio is active in the following markets / industries: biotechnology, therapeutics, Drug discovery and genomics. The company has secured funding across 1 rounds, totaling in an amount of $3M. Their most recent funding was raised on August 3, 2016.
Funding Rounds
Investors of Sequence Bio
Data Collective
Investing in entrepreneurs building deep tech companies
Rounds
S
Killick Capital
Rounds
S
Pelorus Venture Capital Limited
